{
  "ticker": "LLY",
  "timestamp": "2025-12-01T08:55:42.462493",
  "analysis_date": "2025-04-02",
  "historical_mode": true,
  "summary": {
    "recommendations": {
      "technical": "HOLD",
      "news": "HOLD",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "valid_recommendations": {
      "technical": "HOLD",
      "news": "HOLD",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "confidence_levels": {
      "technical": "Low",
      "news": "Medium",
      "fundamental": "Low",
      "macro": "Low"
    },
    "bull_signal_count": 28,
    "bear_signal_count": 17,
    "bull_rec_count": 0,
    "bear_rec_count": 0,
    "hold_rec_count": 4,
    "undetermined_count": 0,
    "analyst_count": 4,
    "valid_analyst_count": 4,
    "net_sentiment": "NEUTRAL"
  },
  "analyst_summaries": {
    "technical": "TECHNICAL: Downtrend confirmed, RSI 14 \u2192 HOLD (Low)",
    "news": "NEWS: Bullish sentiment (91 articles) \u2192 HOLD (Medium)",
    "fundamental": "FUNDAMENTAL: Mixed fundamentals \u2192 HOLD (Low)",
    "macro": "MACRO: Risk-off environment, VIX 21.5 \u2192 HOLD (Low)"
  },
  "full_analyst_reports": {
    "technical": "[TECHNICAL] *** HISTORICAL MODE: Analyzing as of 2025-04-02 ***\n\n======================================================================\nTECHNICAL ANALYSIS: LLY\nAnalysis Period: 7 days\n*** HISTORICAL MODE: As of 2025-04-02 ***\nTimestamp: 2025-12-01 08:54:25\n======================================================================\n\n[TECHNICAL] Fetching 7-day price data for LLY...\n[TECHNICAL] \u2713 Historical: 51 days ending 2025-04-02\n[TECHNICAL]   Date range: 2025-01-21 to 2025-04-02\n[TECHNICAL] \u2713 Retrieved 51 days of data\n[TECHNICAL] Calculating technical indicators...\n[TECHNICAL] \u2713 Indicators calculated\n[TECHNICAL] Identifying support/resistance levels...\n[TECHNICAL] \u2713 Support: $784.91, Resistance: $926.08\n[TECHNICAL] Formatting technical summary...\n[TECHNICAL] Generating analysis with gpt-4o-mini...\n[TECHNICAL] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[TECHNICAL] Creating fallback analysis...\n\n[TECHNICAL] \u2713 Analysis complete in 18.70s\n======================================================================\n\n## Technical Analysis\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-02 \u26a0\ufe0f**\nAll data below is historical, ending on 2025-04-02.\nDo NOT reference any price movements or events after this date.\n\n# Technical Analysis Data for LLY\n\n**Analysis Period:** 7 days (Data: 51 days available)\n**Date:** 2025-04-02\n\n## Price Action\n- **Current Price:** $813.56\n- **Period Change:** -4.00%\n- **Day's Range:** $790.51 - $815.18\n- **Volume:** 2,683,800\n- **Volume Assessment:** Normal levels\n\n## Momentum Indicators\n- **RSI(14):** 55.2 \u2192 Neutral zone\n- **MACD:** -9.081 | Signal: -5.637 | Histogram: -3.444\n  \u2192 Bearish momentum \u26a0\ufe0f\n- **Stochastic:** %K=33.7, %D=31.6\n\n## Moving Average Analysis\n- **SMA_5:** $814.05 (Below \u26a0\ufe0f)\n- **EMA_10:** $821.93 (Below \u26a0\ufe0f)\n- **SMA_20:** $829.01 (Below \u26a0\ufe0f)\n- **SMA_50:** $841.67 (Below \u26a0\ufe0f)\n\n**Trend:** Strong downtrend (price below all MAs) \u26a0\ufe0f\n\n## Volatility & Range\n- **Bollinger Bands:** $778.45 < $813.56 < $879.57\n  \u2192 Middle range (35% position)\n- **ATR:** $22.90 (2.82% of price)\n  \u2192 Normal volatility\n\n## Support & Resistance\n- **Key Resistance:** $926.08\n- **Secondary Resistance:** $902.83\n- **Key Support:** $784.91\n- **Secondary Support:** $790.51\n\n- **Distance to Resistance:** +13.8%\n- **Distance to Support:** +3.7%\n\n## Potential Trade Setup\n- **Setup Type:** SHORT\n- **Entry:** $813.56\n- **Stop Loss:** $847.92 (Risk: $34.35)\n- **Target:** $784.91 (Reward: $28.66)\n- **Risk/Reward Ratio:** 0.83:1\n  \u2192 Poor risk/reward \u26a0\ufe0f\n\n\n---\n\n## Automated Assessment\n\n**Signals Detected:** 0 bullish, 1 bearish\n**Reasoning:** Mixed or weak signals\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "news": "[NEWS] *** HISTORICAL MODE: Analyzing as of 2025-04-02 ***\n\n======================================================================\nNEWS & SENTIMENT ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-04-02 ***\nPeriod: Last 7 days | Sources: ['yahoo', 'finnhub']\nTimestamp: 2025-12-01 08:54:47\n======================================================================\n\n[NEWS] \ud83d\udd27 Fetching Yahoo Finance news...\n[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support\n[NEWS] \u2713 Yahoo Finance: 0 articles\n[NEWS] \ud83d\udd27 Fetching Finnhub news...\n[NEWS] Finnhub: Fetching news from 2025-03-26 to 2025-04-02\n[NEWS] \u2713 Finnhub: 91 articles\n[NEWS] \ud83d\udccb Enhancing 91 articles with background context\n[NEWS] \u26a0\ufe0f Date 2025-04-02 is past LLM knowledge cutoff (2024-01-01)\n[NEWS] \u26a0\ufe0f Skipping LLM context to prevent hallucination\n[NEWS] Analyzing with gpt-4o-mini...\n[NEWS] \u2713 Analysis complete (2179 chars)\n\n[NEWS] \u2713 Analysis complete in 9.45s\n======================================================================\n\n# News & Sentiment Analysis: LLY\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-02 \u26a0\ufe0f**\n**Analysis Period:** Last 7 Days\n**Date:** 2025-12-01 08:54\n\n======================================================================\n\n## Yahoo Finance News (7 Days before 2025-04-02)\n\nNo news found in the specified period\n(Historical mode: news before 2025-04-02)\n## Finnhub News (2025-03-26 to 2025-04-02)\n\n**Found 91 articles**\n\n1. **Big Pharma Avoids Worst-Case Tariff Scenario**\n   - Source: Yahoo\n   - Published: today\n   - Drugmakers breathed a sigh of relief Wednesday after President Trump didn\u2019t announce pharmaceutical tariffs.  Plus, language in the executive order in...\n\n2. **Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch**\n   - Source: Yahoo\n   - Published: today\n   - Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide....\n\n3. **Primary care firm knownwell joins LillyDirect to offer weight-management services**\n   - Source: Yahoo\n   - Published: today\n   - Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's direct-to-consumer online health...\n\n4. **Hims & Hers Zepbound Offering Won\u2019t Bring Needed Sales Boom, Analysts Say**\n   - Source: Yahoo\n   - Published: today\n   - Investors worry patients won\u2019t make that price leap and that Hims, which has built its business on affordable healthcare, will struggle to meet its re...\n\n5. **Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch**\n   - Source: Yahoo\n   - Published: today\n   - Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide....\n\n6. **PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters**\n   - Source: Yahoo\n   - Published: today\n   - Stocks of PFE, MRK, ABBV, LLY and others declined on Tuesday due to uncertainty surrounding Trump's proposed tariffs on pharma imports....\n\n7. **Drug Industry Offers Tepid Pushback to Kennedy\u2019s FDA Job Cuts**\n   - Source: MarketWatch\n   - Published: today\n   - Drug Industry Offers Tepid Pushback to Kennedy\u2019s FDA Job Cuts...\n\n8. **Why April Could Be a Huge Month for Eli Lilly Stock**\n   - Source: Yahoo\n   - Published: today\n   - Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion.  Over the past 12 months, however, the stock...\n\n\n======================================================================\n\n## News & Sentiment Summary\nThe news environment for Eli Lilly (LLY) is currently mixed, with significant attention on the potential impact of tariffs on the pharmaceutical industry, including LLY. While there are concerns regarding pricing and competition, there are also positive developments, such as partnerships aimed at expanding services. Overall, the sentiment appears cautious due to regulatory uncertainties.\n\n## Key Headlines\n1. **Big Pharma Avoids Worst-Case Tariff Scenario** - Positive for LLY as no tariffs were announced; mitigates immediate pricing pressures.\n   - **Impact Assessment:** High\n2. **PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters** - LLY's stock declined due to broader market concerns over tariff implications.\n   - **Impact Assessment:** Medium\n3. **Primary Care Firm Knownwell Joins LillyDirect** - Expansion of services could enhance LLY's market presence in weight management.\n   - **Impact Assessment:** Medium\n4. **Why April Could Be a Huge Month for Eli Lilly Stock** - Speculative bullish sentiment on LLY's potential performance this month.\n   - **Impact Assessment:** Medium\n\n## Sentiment Assessment\n- **Overall Sentiment:** Neutral\n- **Sentiment Trend:** Stable\n- **News Volume:** High\n\n## Catalysts Identified\n**Bullish Catalysts:**\n- Avoidance of pharmaceutical tariffs alleviating immediate concerns for LLY.\n- Partnership with knownwell to enhance service offerings in weight management.\n\n**Bearish Catalysts:**\n- General market decline due to tariff jitters affecting LLY and other pharma stocks.\n- Concerns about competition from Hims regarding obesity treatment.\n\n**Upcoming Events:** Speculation about April being a strong month for LLY's stock performance.\n\n## Trading Implications\nThe news suggests that while there are some positive developments for Eli Lilly, particularly regarding tariff avoidance and strategic partnerships, the overall market sentiment remains cautious. Investors should be aware of potential volatility stemming from broader regulatory concerns and competitive pressures. Given the mixed indicators, a more cautious trading approach is warranted.\n\nRECOMMENDATION: HOLD - Confidence: Medium\n",
    "fundamental": "[FUNDAMENTALS] *** HISTORICAL MODE: Analyzing as of 2025-04-02 ***\n\n======================================================================\nFUNDAMENTAL ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-04-02 ***\nTimestamp: 2025-12-01 08:54:59\n======================================================================\n\n[FUNDAMENTALS] Fetching comprehensive data for LLY...\n[FUNDAMENTALS] \u2713 Comprehensive data retrieved\n[FUNDAMENTALS] Calculating historical metrics for 2025-04-02...\n[FUNDAMENTALS] \u2713 Historical metrics calculated: 4\n[FUNDAMENTALS]   - Price: $813.56\n[FUNDAMENTALS]   - P/E: 89.46\n[FUNDAMENTALS]   - P/B: 46.19\n[FUNDAMENTALS]   - Current Ratio: 1.37\n[FUNDAMENTALS] Analyzing earnings history...\n[FUNDAMENTALS] Filtering earnings to before 2025-04-02\n[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)\n[FUNDAMENTALS] Fetching SEC 10-K filing data...\n[FUNDAMENTALS] Generating analysis with gpt-4o-mini...\n[FUNDAMENTALS] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[FUNDAMENTALS] \u2713 Analysis complete in 19.68s\n======================================================================\n\n## Fundamental Analysis Summary\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-02 \u26a0\ufe0f**\nMetrics marked \"N/A\" could not be calculated historically - ignore them in your analysis.\nOnly analyze metrics with actual values.\n\n# Fundamental Data for LLY\n\n## Company Information\n- **Name:** Eli Lilly and Company\n- **Sector:** Healthcare\n- **Industry:** Drug Manufacturers - General\n\n## Current Price\n- **Price:** $813.56\n- **52-Week High:** $1111.99\n- **52-Week Low:** $623.78\n\n## Valuation Metrics\n- **Market Cap:** $964.11B\n- **Enterprise Value:** $995.68B\n- **Trailing P/E:** 89.46\n- **Forward P/E:** N/A (historical - forward-looking)\n- **PEG Ratio:** N/A (historical)\n- **Price/Book:** 46.19\n- **Price/Sales:** 16.23\n- **EV/Revenue:** 16.76\n- **EV/EBITDA:** 34.66\n\n## Growth Metrics\n- **Revenue Growth:** 53.9%\n- **Earnings Growth:** 480.4%\n- **Quarterly Revenue Growth:** N/A\n- **Quarterly Earnings Growth:** N/A\n\n## Profitability\n- **Profit Margin:** 31.0%\n- **Operating Margin:** 48.3%\n- **Gross Margin:** 83.0%\n- **ROE:** 96.5%\n- **ROA:** 17.6%\n\n## Financial Health\n- **Current Ratio:** 1.37\n- **Quick Ratio:** 0.72\n- **Debt/Equity:** 178.52\n- **Total Cash:** $9.91B\n- **Total Debt:** $42.58B\n- **Free Cash Flow:** $1.40B\n\n## Analyst Opinions\n- **Recommendation:** BUY\n- **Number of Analysts:** 27\n- **Target (Mean):** $1024.00\n- **Target (High):** $1500.00\n- **Target (Low):** $770.00\n- **Implied Upside:** -4.8%\n\n## Earnings History (Last 4 Quarters)\n- Unknown: Actual $5.32 vs Est $5.07 (+5.0%) \u2713 Beat\n- Unknown: Actual $3.34 vs Est $3.54 (-5.7%) \u2717 Miss\n- Unknown: Actual $6.31 vs Est $5.59 (+12.9%) \u2713 Beat\n- Unknown: Actual $7.02 vs Est $5.89 (+19.2%) \u2713 Beat\n\n**Summary:** Beat Rate: 75%, Trend: Declining, Quality: Strong\n\n\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "macro": "[MACRO] *** HISTORICAL MODE: Analyzing as of 2025-04-02 ***\n\n======================================================================\nMACRO ECONOMIC ANALYSIS\nPeriod: 7 days | Sector: All\n*** HISTORICAL MODE: As of 2025-04-02 ***\nTimestamp: 2025-12-01 08:55:21\n======================================================================\n\n[MACRO] Starting iterative analysis...\n[MACRO] Iteration 1/10\n[MACRO] \u274c Error in iterative analysis: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[MACRO] Running fallback mode (no LLM)\n[MACRO] \ud83d\udd27 Tool: get_market_indicators (days=7)\n[MACRO] \u2713 Fetched 6/6 indicators\n[MACRO] \ud83d\udd27 Tool: get_sector_performance (days=7)\n[MACRO] \u2713 Analyzed 9/9 sectors\n[MACRO] \ud83d\udd27 Tool: get_economic_indicators (days=7)\n[MACRO] \u2713 Economic indicators retrieved\n[MACRO] \ud83d\udd27 Tool: get_market_breadth (days=7)\n[MACRO] \u2713 Breadth analysis complete\n\n[MACRO] \u2713 Complete in 20.88s\n======================================================================\n\n# Macro Analysis (7-Day)\n*Generated: 2025-12-01 08:55*\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-04-02**\n\n## Market Indicators (7-Day Analysis)\n\n**\u26a0\ufe0f Historical Data as of: 2025-04-02**\n\n**S&P 500:** 5670.97 | -0.08% | Vol: 16.2% | Strong Downtrend\n**Dow Jones:** 42225.32 | +0.62% | Vol: 13.4% | Sideways\n**NASDAQ:** 17601.05 | -0.84% | Vol: 23.1% | Strong Downtrend\n**VIX (Volatility):** 21.51 | +8.09% | Vol: 106.6% | Strong Uptrend\n**10-Year Treasury:** 4.20 | -1.41% | Vol: 22.1% | Strong Downtrend\n**Russell 2000:** 2045.36 | -1.76% | Vol: 21.1% | Strong Downtrend\n\n## Sector Performance (7-Day)\n\n**\u26a0\ufe0f Historical Data as of: 2025-04-02**\n\n**Leaders:**\n- Consumer Discretionary: +3.38% (Momentum: +0.65%)\n- Consumer Staples: +2.80% (Momentum: +2.36%)\n- Energy: +2.19% (Momentum: +1.39%)\n\n**Laggards:**\n- Industrials: -0.13% (Momentum: -0.19%)\n- Healthcare: -1.40% (Momentum: -1.30%)\n- Technology: -2.33% (Momentum: -1.89%)\n\n**Rotation:** Mixed (+0.62% vs +0.91%) \u2192 NEUTRAL\n\n## Economic Indicators (7-Day)\n\n**\u26a0\ufe0f Historical Data as of: 2025-04-02**\n\n**Dollar Index:** $103.81 | +0.37% \u2192 Neutral\n**Gold:** $3139.90 | +3.43% \u2192 Defensive positioning \u26a0\ufe0f\n**Crude Oil:** $71.71 | +6.77% \u2192 Neutral\n**Bitcoin:** $82485.71 | -5.03% \u2192 Risk aversion \u26a0\ufe0f\n**High Yield Bonds:** $76.20 | -0.27% \u2192 Neutral\n**20Y Treasury:** $89.10 | +0.63% \u2192 Neutral\n\n## Market Breadth (7-Day)\n\n**\u26a0\ufe0f Historical Data as of: 2025-04-02**\n\n**Small vs Large Cap:**\n- S&P 500: -0.08%\n- Russell 2000: -1.76%\n- Spread: -1.69%\n\n**Signal:** Large caps outperforming \u2192 RISK-OFF / Flight to quality \u26a0\ufe0f\n\n\n## Assessment\n\u26a0\ufe0f **Limited Analysis** - LLM unavailable, showing raw data only\n\nRECOMMENDATION: NEUTRAL - Confidence: Low\n\n"
  },
  "bull_evidence": [
    {
      "source": "technical",
      "signal": "[TECHNICAL] \u2713 Support: $784",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "## Momentum Indicators",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Trend:** Strong downtrend (price below all MAs) \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Support:** $784",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Support:** $790",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Support:** +3",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Big Pharma Avoids Worst-Case Tariff Scenario** - Positive for LLY as no tariffs were announced; mitigates immediate pricing pressures",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Primary Care Firm Knownwell Joins LillyDirect** - Expansion of services could enhance LLY's market presence in weight management",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Why April Could Be a Huge Month for Eli Lilly Stock** - Speculative bullish sentiment on LLY's potential performance this month",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bullish Catalysts:**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Upcoming Events:** Speculation about April being a strong month for LLY's stock performance",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "The news suggests that while there are some positive developments for Eli Lilly, particularly regarding tariff avoidance and strategic partnerships, the overall market sentiment remains cautious",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "**Summary:** Beat Rate: 75%, Trend: Declining, Quality: Strong",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "fundamental",
      "signal": "[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Revenue Growth:** 53",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Earnings Growth:** 480",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Quarterly Revenue Growth:** N/A",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "bear_evidence": [
    {
      "source": "technical",
      "signal": "91, Resistance: $926",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Resistance:** $926",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Resistance:** $902",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Resistance:** +13",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Risk/Reward Ratio:** 0",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Poor risk/reward \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Reasoning:** Mixed or weak signals",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters** - LLY's stock declined due to broader market concerns over tariff implications",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "- Stocks of PFE, MRK, ABBV, LLY and others declined on Tuesday due to uncertainty surrounding Trump's proposed tariffs on pharma imports",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- Avoidance of pharmaceutical tariffs alleviating immediate concerns for LLY",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bearish Catalysts:**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- General market decline due to tariff jitters affecting LLY and other pharma stocks",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- Concerns about competition from Hims regarding obesity treatment",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Investors should be aware of potential volatility stemming from broader regulatory concerns and competitive pressures",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "macro",
      "signal": "**Signal:** Large caps outperforming \u2192 RISK-OFF / Flight to quality \u26a0\ufe0f",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "macro",
      "signal": "**Russell 2000:** 2045",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "macro",
      "signal": "03% \u2192 Risk aversion \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "key_conflicts": [],
  "consensus_points": [
    {
      "type": "strong_consensus",
      "recommendation": "HOLD",
      "count": 4,
      "description": "Strong consensus: 4/4 analysts say HOLD"
    }
  ],
  "research_priorities": [
    {
      "priority": "URGENT",
      "focus": "time_sensitive_event",
      "description": "Upcoming catalyst detected",
      "signal": "**Upcoming Events:** Speculation about April being a strong month for LLY's stock performance",
      "source": "news",
      "action": "Research before event occurs"
    }
  ],
  "analyst_reports_summary": {
    "technical": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 2996,
      "has_data": true,
      "completed_successfully": true
    },
    "news": {
      "recommendation": "HOLD",
      "confidence": "Medium",
      "report_length": 5664,
      "has_data": true,
      "completed_successfully": true
    },
    "fundamental": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 3232,
      "has_data": true,
      "completed_successfully": true
    },
    "macro": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 2931,
      "has_data": true,
      "completed_successfully": true
    }
  },
  "data_quality": {
    "status": "COMPLETE",
    "total_analysts": 4,
    "valid_analysts": 4,
    "failed_analysts": 0,
    "failed_list": [],
    "note": null
  },
  "llm_synthesis": "Synthesis error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
  "synthesis_direction": "UNDETERMINED",
  "synthesis_confidence": "N/A"
}